These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11433422)

  • 1. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
    Denmeade SR; Lövgren J; Khan SR; Lilja H; Isaacs JT
    Prostate; 2001 Jul; 48(2):122-6. PubMed ID: 11433422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.
    Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS
    Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
    Bridon DP; Dowell BL
    Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
    Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
    Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation.
    Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY
    J Androl; 1996; 17(6):659-65. PubMed ID: 9016396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
    Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
    Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.
    Takayama TK; Fujikawa K; Davie EW
    J Biol Chem; 1997 Aug; 272(34):21582-8. PubMed ID: 9261179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M; Gibbs BF; Jacobson E; Gagnon C
    Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
    Janssen S; Rosen DM; Ricklis RM; Dionne CA; Lilja H; Christensen SB; Isaacs JT; Denmeade SR
    Prostate; 2006 Mar; 66(4):358-68. PubMed ID: 16302271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
    Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
    Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
    Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
    Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.